Home » Topics » Conferences

Conferences
RSS

Pfizer's antibacterial MC-1 shows promising preclinical activity

Oct. 13, 2010

DC-based TaReNef AIDS vaccine is safe and immunogenic in phase I/II trial

Oct. 13, 2010

AGI-101 improves postsurgery survival in high-risk melanoma

Oct. 11, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

PP-9706642 shows promise as a prophylactic/therapeutic agent for HSV-2 infection

Oct. 11, 2010

Debio-0719 suppresses metastasis in mouse models of breast cancer

Oct. 11, 2010

PTC-299/aromatase inhibitor combinations deemed feasible in breast cancer trial

Oct. 11, 2010

MV-062926 is active in mouse model of COPD

Oct. 8, 2010

Eisai details in vitro and in vivo activity of new antifungal E-1210

Oct. 8, 2010

Extended proof-of-concept and drug interaction studies complete for IDX-899

Oct. 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...